ArticlePrzeglad gastroenterologiczny2021

Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patients.

Magdalena Kaniewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.